| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8247279 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 4 Pages |
Abstract
Conclusion: Tetracaine oral gel administration seemed feasible and safe while reducing RT-induced mucositis-related oral pain in a sizeable proportion of treated head-and-neck cancer patients. A trial designed to compare efficacy of this gel vs. standard treatment is warranted.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Daniela M.D., Barbara Alicja M.D., Ph.D., Gabriele Fulvio Pharm.D., Maria Elena Sc.D., Emanuela Pharm.D., Marcella M.D., Tiziana Pharm.D., Paola (Prof.), Luigi M.D., Ph.D., Roberto Prof.,